Immunomedics, Inc (IMMU) Covered Calls

Immunomedics, Inc covered calls Immunomedics, Inc. is a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

You can sell covered calls on Immunomedics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IMMU (prices last updated Wed 4:16 PM ET):

Immunomedics, Inc (IMMU) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
16.13 -0.85 16.11 16.47 1.7M -11.4 3.2B
Covered Calls For Immunomedics, Inc (IMMU)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 16 1.20 15.27 4.8% 73.0%
Jun 21 16 1.75 14.72 8.7% 53.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Immunomedics, Inc. is a biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. Immunomedics was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.